Files
Document type
ArticleVersion
Published versionPublication date
Publication license
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/158059
Somatostatin and the 'Small-For-Size' Liver
Journal Title
Director/Tutor
Additional contribution
Journal ISSN
Volume Title
Abstract
"Small-for-size" livers arising in the context of liver resection and transplantation are vulnerable to the effects of increased portal flow in the immediate postoperative period. Increased portal flow is an essential stimulus for liver regeneration. If the rise in flow and stimulus for regeneration are excessive; however, liver failure and patient death may result. Somatostatin is an endogenous peptide hormone that may be administered exogenously to not only reduce portal blood flow but also offer direct protection to different cells in the liver. In this review article, we describe key changes that transpire in the liver following a relative size reduction occurring in the context of resection and transplantation and the largely beneficial effects that peri-operative somatostatin therapy may help achieve in this setting.
Related resource
Subject (English)
Citation
Citation
HESSHEIMER, Amelia Judith, et al. Somatostatin and the 'Small-For-Size' Liver. International Journal of Molecular Sciences. 2019. Vol. 20, num. 10, pags. 2512. ISSN 1661-6596. [consulted: 8 of October of 2026]. Available at: https://hdl.handle.net/2445/158059